Healthy Skepticism Library item: 4640

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

Scanlan C .
Unsafe drugs find buyers abroad
MaLAM International Newsletter 1992 Oct 1; 3-6

Abstract:

Drug companies insist that there is no double standard for drugs in developing countries but there is considerable evidence that suggests that there is. MaLAM has documented hundreds of instances of alleged violations of the IFPMA code.

Keywords:
*analysis/developing countries/ attitude toward promotion/ Code of Pharmaceutical Marketing Practices (IFPMA)/ IFPMA/ International Federation of Pharmaceutical Manufacturers Associations/regulation of promotion/MaLAM/Medical Lobby for Appropriate Marketing/company responses/ATTITUDES REGARDING PROMOTION: INDUSTRY/ETHICAL ISSUES IN PROMOTION: COMPANY STANDARDS/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPING COUNTRIES/REGULATION, CODES, GUIDELINES: INDUSTRY SELF-REGULATION